Miltefosine for the treatment of cutaneous leishmaniasis—A pilot study from Ethiopia

BACKGROUND: Cutaneous leishmaniasis (CL) in Ethiopia, caused by Leishmania aethiopica, is often severe and hard to treat compared to CL caused by other species elsewhere. Miltefosine is the only oral anti-leishmanial drug, with a favorable side-effect profile compared to routinely available sodium s...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS Negl Trop Dis
Main Authors: van Henten, Saskia, Tesfaye, Annisa Befekadu, Abdela, Seid Getahun, Tilahun, Feleke, Fikre, Helina, Buyze, Jozefien, Kassa, Mekibib, Cnops, Lieselotte, Pareyn, Myrthe, Mohammed, Rezika, Vogt, Florian, Diro, Ermias, van Griensven, Johan
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2021
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8191986/
https://ncbi.nlm.nih.gov/pubmed/34048461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0009460
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares